Please assess the completion status of the following clinical trial:

Trial Title: Misoprostol for the Treatment of Postpartum Hemorrhage

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Vaginal delivery~* Postpartum hemorrhage due to suspected uterine atony~* Depending on study group: administration of prophylactic uterotonics in third stage of labor~Exclusion Criteria:~* Known allergy to misoprostol or other prostaglandin~* C-section for current delivery

- Gender: FEMALE
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Misoprostol (Type: EXPERIMENTAL): 800 mcg sublingual misoprostol
- Oxytocin (Type: ACTIVE_COMPARATOR): 40 IU Oxytocin IV

Based on this trial design, predict the completion outcome and termination type (if applicable).